S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development of cancer. It is not yet known which regimen of selenium and/or vitamin E may be
more effective in preventing prostate cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of selenium and vitamin E,
either alone or together, in preventing prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI) NCIC Clinical Trials Group
Treatments:
alpha-Tocopherol Selenium Tocopherols Tocotrienols Vitamin E Vitamins